A recent study in patients with advanced RCC demonstrated the occurrence of pathogenic germline mutations in genes predisposing to cancer development in 16.1% of cases, with 5.5% carrying aberrations in syndromic RCC-associated genes, most commonly FH and SDHx [24]. Here, FH is linked to cancer.